Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography.
about
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturyThe safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study.The pharmacokinetics and pharmacodynamics of iron preparations.Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.New frontiers in science and technology: nuclear techniques in nutrition.Iron nutrition in the UK: getting the balance right.The Induction of Oxidative/Nitrosative Stress, Inflammation, and Apoptosis by a Ferric Carboxymaltose Copy Compared to Iron Sucrose in a Non-Clinical Model.Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancyIntravenous iron in inflammatory bowel disease.Ferric carboxymaltose for the treatment of iron-deficiency anemia. [corrected].Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?A nuclear chocolate box: the periodic table of nuclear medicine.Ferric carboxymaltose: a review of its use in iron deficiency.Labile iron in parenteral iron formulations: a quantitative and comparative study.Effects of iron supplementation on erythropoietic response in patients with cancer-associated anemia treated by means of erythropoietic stimulating agents.Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer.Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator.Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial.The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer.The Use of Magnetic Resonance Imaging for Non-Invasive Assessment of Venofer® Biodistribution in Rats.
P2860
Q26752664-E4558044-E4B3-4D01-9FC2-1B868E401BF1Q34000965-55DC311A-7983-44AF-8D97-28E5DF7A17A3Q34039226-6DCEF4CE-2FCA-4660-8728-0FEAB10940A3Q34700903-EC214549-6015-4762-935D-8DABC3156969Q35125398-1E63BF26-08DC-41B8-AC29-1D09DE3466B5Q36098179-D520D5B1-D70D-4AB2-8090-920C0954DBA0Q36476581-855AD992-D822-4681-90F5-662954EEA3CDQ37186219-385A95FA-3292-4F72-9C5E-8EEDD51D874CQ37368728-E22FC2E6-8732-4992-881D-996613546CDDQ37993131-E41192E4-134A-427A-8CD6-B69D7396BA44Q38051056-3FCA69B9-3C80-462C-A130-CFCDA3A51B8AQ38269216-5B1110D6-B142-46E7-902B-E2DE26EA3F6AQ38271890-A63A9404-6844-4CD5-AE3F-EDB8802603D8Q38344983-CB4DC0ED-D428-4B2C-8BFD-AEA910765E08Q38755414-EEACDE23-3F5D-460F-ADDD-7B071A2C748EQ39090576-FED27C8D-E5BC-45F0-9CE6-F954F616EE04Q46783918-2D9CA5B4-9B0F-4AA4-9D78-394FF15AB5C5Q47745978-08CD8743-D552-4BB6-A288-013CF7A8F6DFQ50469154-5C8939C5-6878-41A3-B888-45BAAC88D854Q55400937-1DD6C772-88C0-4230-A5D3-7B0D11357F1F
P2860
Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacokinetics and red cell ...... positron emission tomography.
@ast
Pharmacokinetics and red cell ...... positron emission tomography.
@en
type
label
Pharmacokinetics and red cell ...... positron emission tomography.
@ast
Pharmacokinetics and red cell ...... positron emission tomography.
@en
prefLabel
Pharmacokinetics and red cell ...... positron emission tomography.
@ast
Pharmacokinetics and red cell ...... positron emission tomography.
@en
P2093
P2860
P1476
Pharmacokinetics and red cell ...... positron emission tomography.
@en
P2093
Bo G Danielson
Gunnar Antoni
Hans Lundqvist
Jens Sörensen
Mark Lubberink
Soheir Beshara
Vladimir Tolmachev
P2860
P304
P356
10.1046/J.1365-2141.2003.03590.X
P407
P577
2003-03-01T00:00:00Z